Treatment and Prevention of Acute Hepatitis B Virus

Simone E Dekker; Ellen W Green; Joseph Ahn

doi:10.1016/j.cld.2021.06.002

Treatment and Prevention of Acute Hepatitis B Virus

Clin Liver Dis. 2021 Nov;25(4):711-724. doi: 10.1016/j.cld.2021.06.002. Epub 2021 Sep 9.

Authors

Simone E Dekker¹, Ellen W Green¹, Joseph Ahn²

Affiliations

¹ Department of Medicine, Oregon Health & Science University, 3181 Southwest Sam Jackson Park Road, Portland, OR 97239, USA.
² Division of Gastroenterology and Hepatology, Oregon Health & Science University, 3181 Southwest Sam Jackson Park Road, MNP 4112, Portland, OR 97239, USA. Electronic address: Ahnj@ohsu.edu.

PMID: 34593149
DOI: 10.1016/j.cld.2021.06.002

Abstract

This article reviews the incidence of acute hepatitis B virus (HBV) infection, its clinical course, strategies to prevent acute HBV infection in susceptible individuals, and the management of patients with acute HBV.

Keywords: Acute hepatitis B; Antiviral therapy; Fulminant liver failure; Hepatitis B in newborns; Hepatitis B prevention; Hepatitis B treatment.

Publication types

Review

MeSH terms

Antiviral Agents / therapeutic use
Hepatitis B virus*
Hepatitis B* / drug therapy
Hepatitis B* / epidemiology
Hepatitis B* / prevention & control
Humans

Substances

Antiviral Agents